Prothena plc Stock Pattern Recognition Long Line Candle

PRTA Stock  USD 9.20  0.00  0.00%   
The pattern recognition module provides an execution environment for Long Line Candle recognition and related indicators on Prothena Plc. Signals here center on pattern recognition signals tied to momentum and continuation alongside volatility and performance references.

Recognition
This analysis covers fifty-one data points across the selected time horizon. The function generated a total of twelve valid pattern recognition events for the selected time horizon. The Long Line Candle pattern shows indecision reversal trend for Prothena plc.

Prothena Plc Technical Analysis Modules

Most technical analysis of Prothena Plc help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Prothena from various momentum indicators to cycle indicators. When you analyze Prothena charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

Stock Overview, Methodology & Data Sources

Prothena Corporation plc, a late-stage clinical company, focuses on discovery and development of novel therapies for life-threatening diseases in the United States. The company was founded in 2012 and is based in Dublin, Ireland. Prothena Corp operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 82 people. Downside history and drawdown behavior provide context for risk expectations in Prothena Plc. Past price movements indicate comparatively limited downside dispersion. Prothena Plc has a market cap of 495.8 M, P/E of 37.12, ROE of -63.62%.

Methodology

Unless otherwise specified, financial data for Prothena plc is derived from periodic company reporting (annual and quarterly where available). Asset-level metrics are computed daily by Macroaxis LLC and refreshed regularly based on asset type. Prothena (USA Stocks:PRTA) prices are typically delayed by approximately 20 minutes from primary exchanges for listed equities. Data may be delayed depending on reporting sources and market conventions. Assumptions: Information for Prothena plc is compiled from public filings and market reference sources and official sources including U.S. Securities and Exchange Commission (SEC) via EDGAR and the U.S. Patent & Trademark Office (USPTO). Reporting latency may occur in some cases. All analytics are generated using standardized, rules-based models designed to promote consistency and comparability across instruments. Model assumptions, reference parameters, and selected computational inputs are available in the Model Inputs section. If you have questions about our data sources or methodology, please contact Macroaxis Support.

Analyst Sources

Prothena plc has active sell-side coverage. Source-validated coverage currently shows 7 approved analysts, while broader market-consensus totals may differ across providers due to methodology and update timing. 3 analysts have submitted revenue and/or earnings estimates that may be incorporated into Macroaxis consensus inputs where available. Representative analyst firms may include Jefferies, Raymond James, Goldman Sachs, Bank of America Securities, Morgan Stanley, Deutsche Bank, Wells Fargo Securities, among others. Updates may occur throughout the day.

This content is curated and reviewed by:

Raphi Shpitalnik - Junior Member of Macroaxis Editorial Board
Last reviewed on February 27th, 2026

Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Prothena Plc in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Prothena Plc's short interest history, or implied volatility extrapolated from Prothena Plc options trading.

Trending Themes

If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment.
Momentum Idea
Momentum
Invested few shares
Macroaxis Index Idea
Macroaxis Index
Invested over 60 shares
Hedge Favorites Idea
Hedge Favorites
Invested over 40 shares
Blockchain Idea
Blockchain
Invested few shares
Investor Favorites Idea
Investor Favorites
Invested over 20 shares
Advertising Idea
Advertising
Invested few shares
Warren Buffett Holdings Idea
Warren Buffett Holdings
Invested few shares
Driverless Cars Idea
Driverless Cars
Invested over 40 shares
Cash Cows Idea
Cash Cows
Invested few shares
FinTech Idea
FinTech
Invested over 20 shares
Artificial Intelligence Idea
Artificial Intelligence
Invested few shares

More Resources for Prothena Stock Analysis

A comprehensive view of Prothena plc starts with financial statements and ratio context. Ratios and trend metrics help frame Prothena Plc's operating context across reporting periods. Key reports that frame Prothena plc Stock are listed below:
Prothena Plc has a market cap of 495.8 M, ROE of -63.62%. See Your Equity Center for portfolio-level analysis. The allocation includes a position in Prothena plc in the portfolio view. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.
Explore our How to Trade Prothena Stock guide to learn how to trade Prothena Plc effectively.
At P/E 37.12 and ROE -63.62%, Prothena Plc analysis should be read alongside other portfolio and risk tools before adjusting capital allocation. Checking that valuation and return profile across the analytical tools below produces a more complete investment picture. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
 Earnings Share
-4.53
 Revenue Per Share
0.18
 Quarterly Revenue Growth
-0.99
 Return On Assets
-0.26
 Return On Equity
-0.64
Investors evaluate Prothena plc using market value and book value, each describing different facets of the business. Prothena Plc's market capitalization is 495.8 M. A P/B ratio of 1.77 indicates the market values Prothena Plc above its accounting book value. Enterprise value stands at 196.11 M. Intrinsic value represents an estimate of underlying worth and can differ from both market price and book value. Valuation methods compare these perspectives to frame context.
It is useful to distinguish Prothena Plc's value from its trading price, which are computed with different methods. For Prothena Plc, key inputs include a P/E ratio of 37.12, a P/B ratio of 1.77, ROE of -63.62%, and revenue of 9.68 M. Where Prothena Plc trades at any moment depends on the balance of buying and selling pressure.